Baird upgraded Amicus Therapeutics (NASDAQ: FOLD) from Neutral to Outperform with a price target of $10.00 (from $7.00).ANalyst Michael Ulz ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE